WallStreetZenWallStreetZen

NASDAQ: RXRX
Recursion Pharmaceuticals Inc Stock Ownership - Who owns Recursion Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Recursion Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Najat KhanCEO;Pres2026-09-0822,408$3.52
$78.83kSell
Blake BorgesonDirector2026-09-0130,000$3.34
$100.20kSell
Najat KhanCEO;Pres2026-08-1780,498$3.16
$254.37kSell
David HallettCSci2026-08-1726,657$3.16
$84.24kSell
Ben R. TaylorCFO2026-08-1725,018$3.16
$79.06kSell
Blake BorgesonDirector2026-08-0430,000$3.25
$97.50kSell
Blake BorgesonDirector2026-07-0740,000$3.96
$158.48kSell
Namandje BumpusDirector2026-06-183,963$3.18
$12.60kSell
Ben R. TaylorChief Financial Officer2026-06-155,396$3.15
$17.00kSell
Najat KhanCEO and President2026-06-0523,588$3.58
$84.47kSell

1 of 6

RXRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RXRX insiders and whales buy or sell their stock.

RXRX Shareholders

What type of owners hold Recursion Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Lux Ventures IV LP5.60%30,308,614$96.99MInsider
Dean Y. Li1.72%9,321,306$29.83MInsider
Investment Co Pjsc Mubadala1.31%7,062,869$22.60MInsider
Blake Borgeson1.14%6,158,287$19.71MInsider
Zachary Bogue0.69%3,736,341$11.96MInsider
Data Collective IV LP0.69%3,726,963$11.93MInsider
Najat Khan0.38%2,072,890$6.63MInsider
Michael Secora0.28%1,487,694$4.76MInsider
MIC Capital Partners Public Parallel Cayman LP0.26%1,388,889$4.44MInsider
MIC Capital Partners Public Us IM LLC0.26%1,388,889$4.44MInsider

1 of 3

RXRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RXRX0.07%13.33%Net SellingNet Selling
KARD0.06%71.96%Net BuyingNet Buying
DMRA0.10%26.72%Net SellingNet Selling
MRVI0.05%60.30%Net SellingNet Selling
LKFT0.05%0.00%
View Top Biotech Stocks

Recursion Pharmaceuticals Stock Ownership FAQ

Who owns Recursion Pharmaceuticals?

Recursion Pharmaceuticals (NASDAQ: RXRX) is owned by 0.07% institutional shareholders, 13.33% Recursion Pharmaceuticals insiders, and 86.61% retail investors. Lux Ventures IV LP is the largest individual Recursion Pharmaceuticals shareholder, owning 30.31M shares representing 5.60% of the company. Lux Ventures IV LP's Recursion Pharmaceuticals shares are currently valued at $96.99M.

If you're new to stock investing, here's how to buy Recursion Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.